-
2022/05/13
- Financial Results and Presentation Materials for the 3rd Quarter of the Fiscal Year ending June 2022
-
2022/05/13
- Notice Regarding Establishment of Joint Venture Company (Subsidiary) with QUANTUM Inc.
-
2022/04/12
- Notice Regarding Conclusion of Joint Research Agreement between Asahi Intecc Co., Ltd. and Cuorips Inc.
-
2022/04/04
- Notice Regarding Transition to the Prime Market due to the Reorganization of Tokyo Stock Exchage
-
2022/03/11
- 【Postponed】Participation in CMEF held in Shanghai in Apr 2022
-
2022/05/13
- Financial Results and Presentation Materials for the 3rd Quarter of the Fiscal Year ending June 2022
-
2022/05/13
- Notice Regarding Establishment of Joint Venture Company (Subsidiary) with QUANTUM Inc.
-
2022/04/12
- Notice Regarding Conclusion of Joint Research Agreement between Asahi Intecc Co., Ltd. and Cuorips Inc.
-
2022/04/04
- Notice Regarding Transition to the Prime Market due to the Reorganization of Tokyo Stock Exchage
-
2022/03/10
- Notice Regarding Company Split with Consolidated Subsidiary(Simplified Absorption-type Company Split)
-
2022/03/11
- 【Postponed】Participation in CMEF held in Shanghai in Apr 2022
-
2021/09/02
- A new launch of medical brand product website
-
2021/03/22
- Asahi Intecc to Begin Direct Sales of Endoscopic Guide Wire “M-Through™” in Japan
-
2020/07/16
- Notice Regarding Registration Completion (Incorporation of the Company) of Overseas Sales Sub-Subsidiary “ASAHI INTECC Deutschland GmbH”
-
2020/04/10
- Notice Regarding Establishment of Overseas Sales Sub-subsidiary ASAHI INTECC Deutschland GmbH
